Cited 0 times in
Diabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 조성수 | - |
dc.date.accessioned | 2025-06-27T02:23:59Z | - |
dc.date.available | 2025-06-27T02:23:59Z | - |
dc.date.issued | 2025-03 | - |
dc.identifier.issn | 1936-8798 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/205947 | - |
dc.description.abstract | Background: A heightened prothrombotic environment, combined with premature and more aggressive atherosclerosis, contributes to the elevated cardiovascular risk in patients with diabetes mellitus (DM). Objectives: The aim of this study was to evaluate the association between DM status and thrombogenicity and their prognostic implications in patients with significant coronary artery disease. Methods: A total of 2,501 patients with coronary artery disease undergoing percutaneous coronary intervention, with on-admission glycated hemoglobin and thrombogenicity indexes (measured by thromboelastography). Major adverse cardiovascular events (MACE) were defined as a composite of all-cause death, myocardial infarction, or stroke within 4-year follow-up. Results: Patients with DM (n = 970 [38.8%]) demonstrated significantly higher platelet-fibrin clot strength (PFCS), as indicated by maximal amplitude (median [Q1-Q3]: 67.1 [62.2-72.2] mm vs. 65.5 [61.0-70.4] mm; P < 0.001), and reduced fibrinolytic activity, measured by lysis at 30 minutes (median [Q1-Q3]: 0.1% [0.0%-1.0%] vs. 0.2% [0.0%-1.3%]; P = 0.003), compared to patients without DM. PFCS level was closely related with diabetic status, showing a positive relationship with glycated hemoglobin level up to 7.0% and then reaching a plateau. In a multivariable analysis, high PFCS phenotype defined as maximal amplitude ≥68 mm (HR: 1.39; 95% CI: 1.07-1.81; P = 0.015) and DM phenotype (HR: 1.38; 95% CI: 1.05-1.79; P = 0.018) were independently associated with MACE occurrence. The presence of diabetic phenotype and high PFCS exhibited an additive effect on MACE occurrence (HR: 2.49; 95% CI: 1.77-3.51; P < 0.001). Conclusions: In percutaneous coronary intervention-treated patients, diabetic status and clot-strength value were significantly correlated. High clot-strength phenotype increased the risk for MACE, irrespective of diabetic phenotype. (Gyeongsang National University Hospital Registry [GNUH]; NCT04650529). | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier | - |
dc.relation.isPartOf | JACC-CARDIOVASCULAR INTERVENTIONS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Biomarkers / blood | - |
dc.subject.MESH | Blood Coagulation* | - |
dc.subject.MESH | Coronary Artery Disease* / blood | - |
dc.subject.MESH | Coronary Artery Disease* / diagnosis | - |
dc.subject.MESH | Coronary Artery Disease* / diagnostic imaging | - |
dc.subject.MESH | Coronary Artery Disease* / mortality | - |
dc.subject.MESH | Coronary Artery Disease* / therapy | - |
dc.subject.MESH | Coronary Thrombosis* / blood | - |
dc.subject.MESH | Coronary Thrombosis* / etiology | - |
dc.subject.MESH | Coronary Thrombosis* / mortality | - |
dc.subject.MESH | Diabetes Mellitus* / blood | - |
dc.subject.MESH | Diabetes Mellitus* / diagnosis | - |
dc.subject.MESH | Diabetes Mellitus* / mortality | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Fibrinolysis | - |
dc.subject.MESH | Glycated Hemoglobin / metabolism | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Percutaneous Coronary Intervention* / adverse effects | - |
dc.subject.MESH | Percutaneous Coronary Intervention* / mortality | - |
dc.subject.MESH | Risk Assessment | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Thrombelastography | - |
dc.subject.MESH | Time Factors | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Diabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sungsoo Cho | - |
dc.contributor.googleauthor | Moonki Jung | - |
dc.contributor.googleauthor | Jong-Hwa Ahn | - |
dc.contributor.googleauthor | Min Gyu Kang | - |
dc.contributor.googleauthor | Jae Seok Bae | - |
dc.contributor.googleauthor | Jin-Sin Koh | - |
dc.contributor.googleauthor | Seok-Jae Hwang | - |
dc.contributor.googleauthor | Hwi Seung Kim | - |
dc.contributor.googleauthor | Sang-Wook Kim | - |
dc.contributor.googleauthor | Jin-Yong Hwang | - |
dc.contributor.googleauthor | Young-Hoon Jeong | - |
dc.identifier.doi | 10.1016/j.jcin.2024.12.002 | - |
dc.contributor.localId | A03833 | - |
dc.relation.journalcode | J01193 | - |
dc.identifier.eissn | 1876-7605 | - |
dc.identifier.pmid | 40139850 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1936879824018181 | - |
dc.subject.keyword | cardiovascular event | - |
dc.subject.keyword | clot strength | - |
dc.subject.keyword | coronary artery disease | - |
dc.subject.keyword | diabetes mellitus | - |
dc.subject.keyword | percutaneous coronary intervention | - |
dc.contributor.alternativeName | Cho, Sung Soo | - |
dc.contributor.affiliatedAuthor | 조성수 | - |
dc.citation.volume | 18 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 720 | - |
dc.citation.endPage | 733 | - |
dc.identifier.bibliographicCitation | JACC-CARDIOVASCULAR INTERVENTIONS, Vol.18(6) : 720-733, 2025-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.